CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Best nanotechnology stocks by performance as global demand for advanced materials continues to expand

By Mensholong Lepcha

Edited by Jekaterina Drozdovica

10:15, 21 December 2022

Over the shoulder view of a scientist in protective clothes in a laboratory
Nanotech market is expected to grow at strong pace between 2021 and 2030. Photo – Shutterstock.com / Gorodenkoff

Advancements in nanotechnology have resulted in new innovation across several industries including healthcare, biotechnology, manufacturing, computing and more. 

According to research firm Allied Market Research, the nanotechnology market was expected to grow at a 36% compound annual growth rate between 2021 and 2030, underscoring the growing demand for advanced materials and nanoscience capabilities.

What are the top nanotechnology companies that investors and traders can gain exposure to?  

What is nanotechnology?

Nanotechnology refers to the engineering and application of science at a scale between 1 nanometer to 100 nanometers. It involves the manipulation and control of materials at an atomic and molecular level. One nanometer is a billionth of a metre.

The National Nanotechnology Initiative, a US government and research development initiative, described the field thus:

“Nanoscience and nanotechnology are the study and application of extremely small things and can be used across all the other science fields, such as chemistry, biology, physics, materials science, and engineering.”

 

Nanotechnology is used to tailor materials to achieve specific properties of size, strength, durability, reactivity and conductivity, according to its use. Nanotechnology is utilised across various industries including electronics, computing, healthcare, energy, transportation and environmental.

What is your sentiment on ALNY?

246.80
Bullish
or
Bearish
Vote to see Traders sentiment!

Best nanotechnology stocks 

Developments in the nanotechnology field are disrupting industries and transforming global economies. 

According to the World Economic Forum, breakthroughs in new-age technology fields such as nanotechnology, artificial intelligence, robotics and quantum computing were on the brink of ushering in the “Fourth Industrial Revolution”.

For investors, this presents an opportunity to gain exposure to the forefront of technological innovation. There are numerous top nanotechnology stocks listed on stock exchanges, offering access to owning a part of some of the world’s most innovative companies.

Let’s look at some of the best nanotechnology stocks to buy as we approach 2023. 

Methodology

This list of the best nanotech stocks to watch is based on the S&P Kensho Extended Nanotechnology Index, which is designed to track the performance of nano-materials-producing companies and firms that provide systems, products and services that allow for construction, measurement, simulation or manipulation of nano-materials.

According to ETF provider Direxion, about 81% of the S&P Kensho Extended Nanotechnology constituents were based in the US. The rest were based in Ireland, Israel, Canada, Germany and Bermuda.

A majority of the index constituents belonged to the biotechnology and life sciences tools sector with weights of over 37% and 25%, respectively, as of September 2022.

The following nanotechnology stocks list will include the top 5 biggest S&P Kensho Extended Nanotechnology Index components sorted according to their year-to-date performance, as of 18 December 2022.

Note that stock prices are volatile hence the companies posting gains today may post losses tomorrow. Remember, past performance is not a guarantee of future returns, and always conduct your own due diligence before trading or investing. 

Best nanotechnology stocks

5 best-performing nanotechnology stocks in 2022
Name Sell Buy Spread 1D Chg, %
  • Alnylam Pharmaceuticals

Alnylam Pharmaceuticals (ALNY) was the best year-to-date performer in 2022 among the top 5 constituents on the S&P Kensho Extended Nanotechnology Index.

Alnylam Pharmaceuticals is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for disease with high “unmet medical need”.

“Our RNAi therapeutics are based on RNA interference, a breakthrough discovery in understanding how genes are regulated naturally within cells. Our medicines use RNAi to “silence” or turn off specific genes that cause or contribute to disease,” said the company.

The firm focuses on four main areas of genetic medicines, cardio-metabolic diseases, infectious diseases, and central nervous system (CNS) and ocular diseases. 

Alnylam Pharmaceuticals is listed on the Nasdaq Stock Exchange under the ticker ALNY. In 2022, the stock has posted a year-to-date gain of over 36%, based on its 18 December close of $236.92.

Alnyam Pharmaceuticals stock price

  • Liquidia

Liquidia (LQDA) is a biopharmaceutical company focused on developing products for the treatment of pulmonary arterial hypertension, and is the first firm on our best nanotech stocks list.

The company manufactures drugs using its flagship particle engineering platform called PRINT. Liquidia’s PRINT technology enables the production of highly uniform drug particles with precise control over size, three-dimensional geometric shape and chemical composition.

COIN

278.05 Price
+0.670% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 1.25

NVDA

134.72 Price
+2.780% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 0.13

TSLA

422.33 Price
-3.790% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 0.19

PLTR

80.14 Price
+7.040% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 0.17

According to Liquidia, setting precise physical and chemical parameters enables drug effects such as prolonged duration of drug release, increased drug loading, reduced adverse side effects, deep-lung penetration and more.

Liquidia is listed on the Nasdaq Stock Exchange under the ticker LQDA. In 2022, the stock has posted a year-to-date gain of over 15%, based on its 18 December close of $5.94.

Liquida stock price, 2018 - 2022

  • Bruker

Bruker (BRKR) is a manufacturer of analytical and diagnostic solutions and high-performance scientific instruments.

The company produces devices that help clients observe materials at microscopic, molecular and cellular levels.

The company’s customers come from the fields of life science research, biotechnology, clinical research, microbiology, in-vitro diagnostics and material science research.

Bruker held the second-highest index weight on the S&P Kensho Extended Nanotechnology at over 10.7%, as of September 2022.

The stock is listed on the Nasdaq Stock Exchange under the ticker BRKR. As of 18 December close, Bruker posted a year-to-date loss of over 20%.

Bruker stock price, 2017 - 2022

  • Nano Dimension 

Nano Dimension (NNDM) is a company that provides additively manufactured electronics, printed electronics and micro additive manufacturing solutions.

The company’s flagship three-dimensional (3D) printing system DragonFly IV is used to create electronic circuits and related components in one step, while removing human error, eliminating toxic chemical wastes and reducing energy consumption.

Nano Dimension’s solutions are integrated with artificial intelligence (AI) technology to drive improvements and automation in manufacturing processes. 

The company is based in Israel. Its American depositary shares (ADRs) are listed on the Nasdaq Stock Exchange under the ticker NNDM. In 2022, the stock has posted a year-to-date loss of over 40%, based on its 18 December close of $2.41.

Nano Dimension stock price

  • Bionano Genomics

Bionano Genomics (BNGO) is a company that provides optical genome mapping solutions for genome analysis. 

The company’s optical genome mapping solutions are used in diagnostic services for individuals with genetic conditions such as paediatric neurodevelopmental disorders and  autism spectrum disorders.

Bionano Genomics’ flagship solution Saphyr consists of an instrument, chip consumables, reagents and software containing data analysis and visualisation tools used to identify structural changes in chromosomes.

The company is listed on the Nasdaq Stock Exchange under the ticker BNGO. In 2022, the stock posted a year-to-date loss of over 44%, based on its 18 December close of $1.8.

Bionano Genomics stock price

Final thoughts

Most nanotechnology stocks have endured a difficult period in 2022 due to the ongoing increases in interest rates. The nanotech industry is a highly capital-intensive sector which needs massive amounts of capital to fund innovation that may or may not result in sales and profits. Therefore, the stock market performance of nanotech companies can be susceptible to rising benchmark lending rates.

If you are interested in investing in some of the best nanotechnology stocks available on listed markets, it is important to conduct your own due diligence. Forecasts can be wrong.

Keep in mind that past performance is no guarantee of future returns. And never trade money that you cannot afford to lose.

FAQs

Is nanotechnology a good investment?

If you are interested in investing in nanotechnology stocks available on listed markets, it is important to conduct your own due diligence, looking at the latest news, a wide range of analyst commentary, technical and fundamental analysis. Keep in mind that past performance is no guarantee of future returns. And never trade money that you cannot afford to lose.

Will nanotechnology stocks go up?

No-one knows for certain. Stock markets are volatile and are considered risky investments. Keep in mind that past performance is no guarantee of future returns.

Should I invest in nanotechnology stocks?

Your decision to invest should be based on your research, experience, risk tolerance and other important factors. It is important to conduct your own due diligence. Keep in mind that past performance is no guarantee of future returns. And never trade money that you cannot afford to lose.

Markets in this article

ALNY
Alnylam
246.80 USD
7.2 +3.030%
BNGO
Bionano Genomics, Inc.
0.2023 USD
-0.0052 -2.590%
LQDA
Liquidia Technologies, Inc.
11.14 USD
0.5 +4.750%

Related topics

Rate this article

Related reading

The difference between trading assets and CFDs
The main difference between CFD trading and trading assets, such as commodities and stocks, is that you don’t own the underlying asset when you trade on a CFD.
You can still benefit if the market moves in your favour, or make a loss if it moves against you. However, with traditional trading you enter a contract to exchange the legal ownership of the individual shares or the commodities for money, and you own this until you sell it again.
CFDs are leveraged products, which means that you only need to deposit a percentage of the full value of the CFD trade in order to open a position. But with traditional trading, you buy the assets for the full amount. In the UK, there is no stamp duty on CFD trading, but there is when you buy stocks, for example.
CFDs attract overnight costs to hold the trades (unless you use 1-1 leverage), which makes them more suited to short-term trading opportunities. Stocks and commodities are more normally bought and held for longer. You might also pay a broker commission or fees when buying and selling assets direct and you’d need somewhere to store them safely.
Capital Com is an execution-only service provider. The material provided in this article is for information purposes only and should not be understood as investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents and has not been prepared in accordance with the legal requirements designed to promote investment research independence. While the information in this communication, or on which this communication is based, has been obtained from sources that Capital.com believes to be reliable and accurate, it has not undergone independent verification. No representation or warranty, whether expressed or implied, is made as to the accuracy or completeness of any information obtained from third parties. If you rely on the information on this page, then you do so entirely at your own risk.

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading